Old Web
English
Sign In
Acemap
>
authorDetail
>
Kei Watabe
Kei Watabe
Internal medicine
Placebo
Lurasidone
Medicine
Adverse effect
5
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study.
2021
International Journal of Bipolar Disorders
Teruhiko Higuchi
Tadafumi Kato
Mari Miyajima
Kei Watabe
Takahiro Masuda
Katsuhiko Hagi
Jun Ishigooka
Show All
Source
Cite
Save
Citations (0)
Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study
2021
Journal of Affective Disorders
Jun Ishigooka
Tadafumi Kato
Mari Miyajima
Kei Watabe
Takahiro Masuda
Katsuhiko Hagi
Teruhiko Higuchi
Show All
Source
Cite
Save
Citations (2)
Corrigendum to "Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study". [Journal of Affective Disorders 281 (2021) 160-167].
2021
Journal of Affective Disorders
Jun Ishigooka
Tadafumi Kato
Mari Miyajima
Kei Watabe
Takahiro Masuda
Katsuhiko Hagi
Teruhiko Higuchi
Show All
Source
Cite
Save
Citations (0)
Double-Blind, Placebo-Controlled Study of Lurasidone Monotherapy for the Treatment of Bipolar I Depression.
2020
Psychiatry and Clinical Neurosciences
Tadafumi Kato
Jun Ishigooka
Mari Miyajima
Kei Watabe
Tomohiro Fujimori
Takahiro Masuda
Teruhiko Higuchi
Eduard Vieta
Show All
Source
Cite
Save
Citations (5)
Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study.
2019
Schizophrenia Research
Nakao Iwata
Jun Ishigooka
Won-Hyoung Kim
Bo Hyun Yoon
Shih-Ku Lin
Ahmad Hatim Sulaiman
Rowena Cosca
Lina Wang
Yury Suchkov
Alexey Agarkov
Kei Watabe
Tomohito Matsui
Takayuki Sato
Yoshifumi Inoue
Teruhiko Higuchi
Christoph U. Correll
John M. Kane
Show All
Source
Cite
Save
Citations (18)
1